These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 11709712)

  • 41. Genome Profiling for Aflatoxin B
    St John N; Freedland J; Baldino H; Doyle F; Cera C; Begley T; Fasullo M
    G3 (Bethesda); 2020 Nov; 10(11):3929-3947. PubMed ID: 32994210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The oncogene mcts1.
    Hachem A; Nandi S
    Transl Oncogenomics; 2007; 2():79-84. PubMed ID: 23645982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and purification of recombinant human MCT-1 oncogene in insect cells.
    Pérez-Arellano I; Gozalbo-Rovira R; Martínez AI; Cervera J
    Protein J; 2010 Feb; 29(2):69-74. PubMed ID: 20076993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
    Nandi S; Reinert LS; Hachem A; Mazan-Mamczarz K; Hagner P; He H; Gartenhaus RB
    Oncogene; 2007 Apr; 26(16):2283-9. PubMed ID: 17016429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel candidate oncogene, MCT-1, is involved in cell cycle progression.
    Prosniak M; Dierov J; Okami K; Tilton B; Jameson B; Sawaya BE; Gartenhaus RB
    Cancer Res; 1998 Oct; 58(19):4233-7. PubMed ID: 9766643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
    Dierov J; Prosniak M; Gallia G; Gartenhaus RB
    J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells.
    Hsu HL; Shi B; Gartenhaus RB
    Oncogene; 2005 Jul; 24(31):4956-64. PubMed ID: 15897892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells.
    Jirmanova L; Afanassieff M; Gobert-Gosse S; Markossian S; Savatier P
    Oncogene; 2002 Aug; 21(36):5515-28. PubMed ID: 12165850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and stabilization of the MCT-1 protein by DNA damaging agents.
    Herbert GB; Shi B; Gartenhaus RB
    Oncogene; 2001 Oct; 20(46):6777-83. PubMed ID: 11709712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.